The effect of blood glucose regulation on retinal nerve fiber layer thickness in diabetic patients

Lonneville Y., Ozdek Ş., Onol M., Yetkin I., Gurelik G., Hasanreisoglu B.

OPHTHALMOLOGICA, cilt.217, sa.5, ss.347-350, 2003 (SCI-Expanded) identifier identifier identifier

  • Yayın Türü: Makale / Tam Makale
  • Cilt numarası: 217 Sayı: 5
  • Basım Tarihi: 2003
  • Doi Numarası: 10.1159/000071350
  • Dergi Adı: OPHTHALMOLOGICA
  • Derginin Tarandığı İndeksler: Science Citation Index Expanded (SCI-EXPANDED), Scopus
  • Sayfa Sayıları: ss.347-350
  • Anahtar Kelimeler: diabetes mellitus, metabolic regulation, nerve fiber layer thickness, RETROGRADE AXONAL-TRANSPORT, OPEN-ANGLE GLAUCOMA, INTRAOCULAR-PRESSURE, MELLITUS
  • Gazi Üniversitesi Adresli: Evet

Özet

Purpose: To evaluate the effect of blood glucose (BG) regulation on the retinal nerve fiber layer (RNFL) in diabetic patients by using a scanning laser polarimeter (NFA-GDx). Methods: We prospectively assessed RNFL thickness in diabetic patients and an age-matched control group. Patients without diabetic retinopathy, with BG >250 mg/dl, HbA1c >8%, fructosamine >285 mumol/l and triglyceride >200 mg/dl were included in the study. RNFL assessment was performed before and after metabolic regulation of diabetes. Symmetry, superior maximum, ellipse modulation and the average thickness variables of NFA-GDx were used for the assessment. Mann-Whitney U and Wilcoxon tests were used for the statistical analysis. Results: A total of 40 diabetic patients were included in the study and a repeat RNFL examination could be performed in 22 of them following regulation of BG levels. None of the GDx variables were significantly different between pre- and postregulation measurements (p > 0.05, Wilcoxon test). The mean superior maximum, ellipse modulation and average thickness values of the diabetic group were significantly lower than the control group (p < 0.05, Mann-Whitney U-test). Conclusions: Poor metabolic control of diabetes mellitus adversely affects the thickness of RNFL and this effect does not seem to be acute since it was not reversed by short-term BG regulation. This issue needs to be kept in mind when assessing glaucomatous progress in diabetic patients. Copyright (C) 2003 S. Karger AG, Basel.